Invitrogen has appointed Benjamin Bulkley to the position of senior vice president of commercial operations. Bulkley most recently served as vice president of global services for General Electric’s Medical Systems Information Technologies division. Invitrogen has also promoted John Thompson from vice president of corporate development to senior vice president of corporate development.
Inpharmatica has appointed Edwin Moses as non-executive chairman. Moses has been a non-executive director of the company since July 2001. Sir Harry Solomon, the company’s former chairman, will remain a board director. Moses was previously CEO of Oxford Asymmetry International. Malcolm Weir, Inpharmatica CEO, said the company’s recent transition to a drug discovery business model “has brought with it the need for a chairman experienced in the healthcare sector to help management guide the company through the next stage in its evolution.”